ロード中...
Lupus anticoagulant and mortality in patients hospitalized for COVID-19
Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant profile of COVID-19. However, the association betwe...
保存先:
| 出版年: | J Thromb Thrombolysis |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648549/ https://ncbi.nlm.nih.gov/pubmed/33159639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02335-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|